Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome

BACKGROUND

Cardiac autonomic function may play a role in obesity-associated hypertension. Most studies on the effects of weight loss on blood pressure and autonomic function do not distinguish between acute or continuing weight loss and steady-state weight maintenance after weight loss.

OBJECTIVES

We sought to clarify the changes in ambulatory blood pressure, heart rate and heart rate variability as assessed by spectral analysis during rapid weight loss and extended weight maintenance.

PARTICIPANTS

Abdominally obese (body mass index 35.2 +/- 2.1 kg/m2, waist 114.3 +/- 9.0 cm) men and women (n = 41) with the metabolic syndrome.

METHODS AND RESULTS

The 34 men and women completing the 1-year weight maintenance period lost 14.6 +/- 3.5 kg during the 9-week very-low-calorie diet and maintained a 12.5 +/- 7.5 kg weight loss to the end of the trial. Ambulatory 24-h blood pressure decreased dramatically during the diet (-9.0 +/- 8.0/-4.6 +/- 4.9 mmHg), but had risen to near baseline levels by the end of weight maintenance (-2.2 +/- 8.2 /-1.2 +/- 6.1 mmHg). Night-time heart rate decreased (-5.5 +/- 9.6 beats/min, P = 0.012), and heart rate variability total and low-frequency power measured during 5 min of controlled breathing increased by 46-56% (P = 0.003-0.09) during rapid weight loss. These changes gradually attenuated during weight maintenance, and only the change in night-time heart rate was still of borderline significance after 1 year of weight maintenance (-3.6 +/- 8.6 beats/min, P = 0.063). Heart rate variability high-frequency power tended to increase during weight loss and weight maintenance.

CONCLUSION

Despite successful weight maintenance, the decrease in ambulatory blood pressure after rapid weight loss was largely transient. The increase in parasympathetic tone was more sustained, but also gradually attenuated during 1 year of weight maintenance.

[Eradication of Chorioptes bovis mange in a dairy herd with turn-out to graze by Eprinex Pour-On]

The possibility to control or even eradicate chorioptes manage by a single herd treatment with EPRINEX Pour-On (dosage: 0.5 mg Eprinomection/kg bodyweight) during pasture season was investigated in a dairy herd of 320 dairy cows. A further aim of the study was to evaluate whether such mid-summer treatment with EPRINEX Pour-On due to its endo-ectocide action would at the same time also result in a metaphylaxis of gastro-intestinal and lung worms and in a reduction of fly infestation. Due to clinical symptoms manage prevalence in the herd prior to treatment was 11 percent. After treatment, clinical symptoms disappeared within 2 months completely and did not re-occur during the subsequent housing period. Chorioptes mites during the entire trial period no longer were detected. The final clinical and parasitological investigation shortly before turn-out the next year (April 1999) demonstrated chorioptes mange to be eradicated clinically and parasitologically. Due to the mid-summer treatment infestation with gastrointestinal helminths also was eliminated and clinical symptoms of helminth infestations during the pasture season no longer were observed. However, at housing in November, low numbers of eggs of gastrointestinal nematodes were detected in 6% of dairy cows, 32% of second-season and 63% of first-season heifers, respectively. Milk yield per cow and day on average increased by 1 litre after treatment with EPRINEX Pour-On. This increase in production is likely a result of the reduction in total parasite burden of lactating cows.